DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

IL-11 in the Development of Multiple Sclerosis

Conditions: Multiple Sclerosis

First Posted Date: 2018-11-08

Last Posted Date: 2022-06-06

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 96

Registration Number: NCT03735823

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis

Phase 1

Completed

Conditions: Peritoneal Dialysis-associated Peritonitis

Interventions: Drug: Vancomycin

First Posted Date: 2018-09-26

Last Posted Date: 2022-03-03

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 4

Registration Number: NCT03685747

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen

Completed

Conditions: Weight Gain
Renal Function Abnormal
HIV-1-infection
Metabolic Syndrome
Cardiovascular Diseases
Hyperglycemia

First Posted Date: 2018-08-24

Last Posted Date: 2019-09-23

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 110

Registration Number: NCT03646370

Locations: 🇺🇸
Thomas Jeffeson University, Philadelphia, Pennsylvania, United States

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure

Phase 1

Completed

Conditions: Neonatal Abstinence Syndrome
Neonatal Opiate Withdrawal Syndrome

Interventions: Drug: Buprenorphine

First Posted Date: 2018-08-01

Last Posted Date: 2022-02-11

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 10

Registration Number: NCT03608696

Locations: 🇺🇸
Thomas Jefferson University Hosptial, Philadelphia, Pennsylvania, United States

Enhancing Postpartum Discharge Instructions

Not Applicable

Completed

Conditions: Health Literacy
Postpartum
Cesarean Delivery Affecting Newborn
Randomized Controlled Trial

Interventions: Other: Standard Instructions
Other: Visual Aid

First Posted Date: 2018-07-19

Last Posted Date: 2018-07-19

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 50

Registration Number: NCT03592628

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Comparative Analysis of Sutures for Fascial Closure in Spinal Surgery

Not Applicable

Completed

Conditions: Fusion of Spine

Interventions: Device: Barbed

First Posted Date: 2018-05-23

Last Posted Date: 2023-12-06

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT03533595

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Breastfeeding Education Support Tool for Baby

Not Applicable

Completed

Conditions: Breastfeeding

Interventions: Other: Breastfeeding counseling and education services

First Posted Date: 2018-05-23

Last Posted Date: 2022-05-31

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 247

Registration Number: NCT03533725

Locations: 🇮🇳
Jawaharlal Nehru Medical College, Belgaum, Karnataka, India

Entecavir to TAF Switch

Phase 3

Active, not recruiting

Conditions: Hepatitis B

Interventions: Drug: Tenofovir Alafenamide

First Posted Date: 2018-04-05

Last Posted Date: 2020-06-25

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 27

Registration Number: NCT03489239

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Reducing Emergency Diabetes Care for Older African Americans

Phase 3

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: PREVENT
Behavioral: EUC (Enhanced Usual Care)

First Posted Date: 2018-03-15

Last Posted Date: 2024-05-14

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 156

Registration Number: NCT03466866

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study

Early Phase 1

Terminated

Conditions: Achalasia

Interventions: Drug: Mirabegron 50 MG
Drug: Placebo

First Posted Date: 2018-01-26

Last Posted Date: 2021-03-24

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 5

Registration Number: NCT03411252

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy